相似文献
1
[Molecular target therapy for malignant tumors].
Nihon Naika Gakkai Zasshi. 2005 Feb 20;94 Suppl:76-80.
2
[Molecular targeted therapy for malignant brain tumors].
Nihon Rinsho. 2005 Sep;63 Suppl 9:520-6.
3
[Antineoplastic agents targeting tyrosine kinases].
Tidsskr Nor Laegeforen. 2005 Nov 17;125(22):3115-9.
4
[Prognostic molecular marker and molecular targeted-therapy in pediatric malignancies].
Gan To Kagaku Ryoho. 2007 Feb;34(2):194-202.
5
Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
Surg Today. 2004;34(4):293-303. doi: 10.1007/s00595-003-2710-4.
6
[Problems in the current target therapy of malignancies].
Vopr Onkol. 2005;51(5):607-11.
7
A widening prospect: Imatinib and novel applications of targeted therapy.
Semin Oncol. 2004 Apr;31(2 Suppl 6):1-3. doi: 10.1053/j.seminoncol.2004.03.033.
8
[Kinase inhibitors].
Nihon Rinsho. 2010 Jun;68(6):1059-66.
9
[Resistance to target-based therapy and its circumvention].
Nihon Rinsho. 2004 Jul;62(7):1343-7.
10
[Molecular target therapy for hematologic malignancy].
Nihon Naika Gakkai Zasshi. 2004 Mar 10;93(3):460-4. doi: 10.2169/naika.93.460.
Zotero 插件